Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Infection
Published in: Infection 1/2018

01-02-2018 | Case Report

Tinea corporis caused by Trichophyton equinum in a rider and review of the literature

Authors: Stefano Veraldi, Giovanni Genovese, Andrea Peano

Published in: Infection | Issue 1/2018

Login to get access

Abstract

Background

Trichophyton equinum is a zoophilic dermatophyte usually causing ringworm in horses. Cases of skin infections in humans are very rare.

Case report 

​We describe a case of tinea corporis caused by T. equinum on a buttock of a rider who often rode bareback with short trousers.

Conclusion

Although T. equinum was considered in the past as a strict zoophilic dermatophyte, our case report confirms that it can cause dermatophytoses also in humans. A review of epidemiological and clinical features of human infections caused by T. equinum is presented.
Literature
1.
Walker J. The dermatophytoses of Great Britain report of a three years’ survey. Br J Dermatol Syph. 1950;62:239–51.CrossRefPubMed
2.
3.
Marais V, Olivier DL. A human case of Trichophyton equinum infection. S Afr Med J. 1963;37:35.PubMed
4.
Otčenášek M, Dvořák J, Šabatová M, Horáková E. Zwei Befunde des Trichophyton equinum (Matruchot et Dassonville) Gedoelst 1902 in menschlichen Läsionen. Dermatol Wochenschr. 1964;149:438–40.PubMed
5.
English MP. The epidemiology of animal ringworm in man. Br J Dermatol. 1972;86(Supp 8):78–87.CrossRef
6.
Maslen M, Thompson PG. Human infections due to Trichophyton equinum var. autotrophicum in Victoria. Australas J Dermatol. 1984;25:29–32.CrossRefPubMed
7.
Takatori K, Ichijo S. Human dermatophytosis caused by Trichophyton equinum. Mycopathologia. 1985;90:15–9.CrossRefPubMed
8.
Nicholls DSH, Midgley G. Onychomycosis caused by Trichophyton equinum. Clin Exp Dermatol. 1989;14:464–5.CrossRefPubMed
9.
Pereiro Miguens M, Pereiro M, Pereiro M Jr. Review of dermatophytoses in Galicia from 1951 to 1987, and comparison with other areas of Spain. Mycopathologia. 1991;113:65–78.CrossRefPubMed
10.
Shwayder T, Andreae M, Babel D. Trichophyton equinum from riding bareback: first reported U.S. case. J Am Acad Dermatol. 1994;30:785–7.CrossRefPubMed
11.
Burden AD, Tillman DM, Richardson MD. Human Trichophyton equinum infection treated with terbinafine. Clin Exp Dermatol. 1994;19:359–60.CrossRefPubMed
12.
Brasch J, Fölster-Holst R, Christophers E. Tinea durch Trichophyton equinum. Hautarzt. 1998;49:397–402.CrossRefPubMed
13.
Huovinen S, Tunnela E, Huovinen P, Kuijpers AFA, Suhonen R. Human onychomycosis caused by Trichophyton equinum transmitted from a racehorse. Br J Dermatol. 1998;138:1082–4.CrossRefPubMed
14.
Amor E, Gutiérrez MJ, Lamoneda C, del Palacio A, Pereiro M. Terbinafine treatment of Trichophyton equinum infection in a child. Clin Exp Dermatol. 2001;26:276–8.CrossRefPubMed
15.
Ng KP, Soo-Hoo TS, Na SL, Ang LS. Dermatophytes isolated from patients in University Hospital, Kuala Lumpur. Malaysia. Mycopathol. 2002;155:203–6.CrossRef
16.
Brasch J, Lögering B, Gräser Y. Tinea capitis caused by Trichophyton equinum. Acta Derm Venereol. 2009;89:204–5.CrossRefPubMed
17.
Georg LK, Kaplan W, Camp LB. Trichophyton equinum—a re-evaluation of its taxonomic status. J Invest Dermatol. 1957;29:27–37.CrossRefPubMed
18.
Rieth H, Splanemann V. Zur Unterscheidung von Trichophyton mentagrophytes, Trichophyton quinckeanum und Trichophyton equinum mit Hilfe des Nikotinsäuretests. Mycoses. 1970;13:617–8.CrossRef
19.
Preuett BL, Schuenemann E, Brown JT, Kovac ME, Krishnan SK, Abdel-Rahman SM. Comparative analysis of secreted enzymes between the anthropophilic-zoophilic sister species Trichophyton tonsurans and Trichophyton equinum. Fungal Biol. 2010;114:429–37.CrossRefPubMed
20.
Rezaei-Matehkolaei A, Makimura K, De Hoog GS, Shidfar MR, Satoh K, Najafzadeh MJ, Mirhendi H. Discrimination of Trichophyton tonsurans and Trichophyton equinum by PCR-RFLP and by β-tubulin and translation elongation factor 1-α sequencing. Med Mycol. 2012;50:760–4.CrossRefPubMed
Metadata
Title
Tinea corporis caused by Trichophyton equinum in a rider and review of the literature
Authors
Stefano Veraldi
Giovanni Genovese
Andrea Peano
Publication date
01-02-2018
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 1/2018
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-017-1067-3

Other articles of this Issue 1/2018

Infection 1/2018 Go to the issue

Original Paper

Pertussis and parapertussis in children and adults with a persistent cough: an observational study

Correspondence

Difficulties in establishing the source of infection in recurrent neonatal group B streptococcal disease

Original Paper

Effectiveness of kidney transplantation in HIV-infected recipients under combination antiretroviral therapy: a single-cohort experience (Brescia, Northern Italy)

Case Report

A case of Q fever with erythema nodosum

Correspondence

Correspondence to “Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever”

Original Paper

Improvement of semen parameters after antibiotic therapy in asymptomatic infertile men infected with Mycoplasma genitalium
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits